Page last updated: 2024-09-03

buthionine sulfoximine ethyl ester and Idiopathic Parkinson Disease

buthionine sulfoximine ethyl ester has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, JK; Kaur, D; Lee, D; Ragapolan, S1

Other Studies

1 other study(ies) available for buthionine sulfoximine ethyl ester and Idiopathic Parkinson Disease

ArticleYear
Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease.
    Free radical biology & medicine, 2009, Mar-01, Volume: 46, Issue:5

    Topics: Animals; Cell Line, Transformed; Dopamine; Endocytosis; Glutathione; Hydrogen Peroxide; Hypoxia-Inducible Factor 1; Iron; Iron Regulatory Protein 1; Mesencephalon; Methionine Sulfoximine; Neurons; Oxidative Stress; Parkinson Disease; Protein Biosynthesis; Rats; Reactive Oxygen Species; Receptors, Transferrin

2009